What is the current Poxel market capitalization?
The current market capitalization of Poxel is 7.04 M EUR.
Poxel Market capitalization 2025
Poxel Market capitalization
7.04 M EUR
Ticker
POXEL.PA
ISIN
FR0012432516
WKN
A14M04
In 2025, Poxel's market cap stood at 7.04 M EUR, a -55.58% increase from the 15.85 M EUR market cap in the previous year.
The Poxel Market capitalization history
| YEAR | Market Capitalization (undefined EUR) |
|---|---|
| 2023 | 20.79 |
| 2022 | 63.65 |
| 2021 | 180.66 |
| 2020 | 207.69 |
| 2019 | 183.6 |
| 2018 | 163.18 |
| 2017 | 146.51 |
| 2016 | 194.29 |
| 2015 | 220.09 |
| 2014 | - |
| 2013 | - |
| 2012 | - |
| 2011 | - |
Poxel Aktienanalyse
What does Poxel do?
Poxel SA is a biopharmaceutical company focused on developing drugs for the treatment of metabolic disorders, particularly type 2 diabetes. The company was founded in Lyon, France, in 2009. Poxel SA's business model is based on the targeted development of drugs for the treatment of metabolic disorders with high medical demand and large market potential. The company focuses on identifying drug candidates that are highly specific and effective while also having a favorable safety profile. Poxel SA collaborates closely with academic research and the industry to leverage the latest knowledge and technologies in drug development. Over the years, Poxel SA has become a leading company in metabolism medicine, with an extensive product pipeline of promising drug candidates. The product range includes both preclinical and clinical candidates, as well as products in advanced stages of clinical development. One of Poxel SA's main products is Imeglimin, a drug for the treatment of type 2 diabetes. Imeglimin is a new active ingredient that acts on the metabolic disorder in a novel way and improves the body's glucose metabolism. The drug is currently in the final phase of clinical development and has shown promising results in previous studies. Another promising product from Poxel SA is PXL770, a drug for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). PXL770 is a novel active ingredient that acts on the body's AMP-activated protein kinase system and regulates lipid and glucose metabolism. The drug is still in the clinical development phase but has already shown promising results. Another promising product group from Poxel SA are the adenosine monophosphate (AMP) activators, which are also being developed for the treatment of metabolic disorders such as type 2 diabetes and fatty liver disease. The AMP activators act on the body's AMP-activated protein kinase system and regulate lipid and glucose metabolism. Poxel SA also works closely with partners in the pharmaceutical industry to develop and bring innovative drug candidates to the market. The company has partnerships with leading companies such as Sumitomo Dainippon Pharma, Roivant Sciences, and Servier to expand and diversify its product pipeline. Overall, Poxel SA is an emerging company in metabolism medicine, focusing on the development of innovative drugs for the treatment of metabolic disorders. With a strong product pipeline and proven collaboration with academia and the industry, Poxel SA is a promising player in this growing market. Poxel ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Poxel's Market Capitalization
Poxel's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Poxel's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Poxel's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Poxel’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Poxel stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Poxel.
How has the market capitalization of Poxel developed in recent years?
The market capitalization of Poxel has increased/decreased by -55.58% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Poxel?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Poxel?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Poxel have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Poxel pay?
Over the past 12 months, Poxel paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Poxel is expected to pay a dividend of 0 EUR.
What is the dividend yield of Poxel?
The current dividend yield of Poxel is .
When does Poxel pay dividends?
Poxel pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Poxel?
Poxel paid dividends every year for the past 0 years.
What is the dividend of Poxel?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Poxel located?
Poxel is assigned to the 'Health' sector.
Wann musste ich die Aktien von Poxel kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Poxel from 2/25/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 2/25/2025.
When did Poxel pay the last dividend?
The last dividend was paid out on 2/25/2025.
What was the dividend of Poxel in the year 2024?
In the year 2024, Poxel distributed 0 EUR as dividends.
In which currency does Poxel pay out the dividend?
The dividends of Poxel are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Poxel stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Poxel
Our stock analysis for Poxel Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Poxel Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
